Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1053)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$520.62
Total Value
$208.25K
Shares Held After
324,483
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
476
Price
$519.35
Total Value
$247.21K
Shares Held After
324,883
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,790
Price
$518.35
Total Value
$927.85K
Shares Held After
325,359
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,516
Price
$517.49
Total Value
$1.82M
Shares Held After
327,149
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,128
Price
$516.70
Total Value
$582.83K
Shares Held After
330,665
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,591
Price
$515.41
Total Value
$820.01K
Shares Held After
331,793
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
559
Price
$514.64
Total Value
$287.68K
Shares Held After
333,384
% of Holdings
0.2%
REGENXBIO Inc. (RGNX)
Ciongoli Gregory Austin — Director
Shares
49,196
Price
$9.14
Total Value
$449.71K
Shares Held After
64,628
% of Holdings
76.1%
Monopar Therapeutics (MNPR)
RIOUX PATRICE — Acting Chief Medical Officer
Shares
1
Price
$111.26
Total Value
$111.26
Shares Held After
5,065
% of Holdings
0.0%
Monopar Therapeutics (MNPR)
Tsuchimoto Kim R — Director
Shares
590
Price
$113.84
Total Value
$67.17K
Shares Held After
7,396
% of Holdings
7.4%
Monopar Therapeutics (MNPR)
Tsuchimoto Kim R — Director
Shares
602
Price
$112.93
Total Value
$67.98K
Shares Held After
7,986
% of Holdings
7.0%
Monopar Therapeutics (MNPR)
Tsuchimoto Kim R — Director
Shares
1,098
Price
$111.84
Total Value
$122.80K
Shares Held After
8,588
% of Holdings
11.3%
Monopar Therapeutics (MNPR)
Tsuchimoto Kim R — Director
Shares
700
Price
$110.65
Total Value
$77.45K
Shares Held After
9,686
% of Holdings
6.7%
Monopar Therapeutics (MNPR)
Tsuchimoto Kim R — Director
Shares
615
Price
$109.56
Total Value
$67.38K
Shares Held After
10,386
% of Holdings
5.6%
Monopar Therapeutics (MNPR)
Tsuchimoto Kim R — Director
Shares
485
Price
$108.83
Total Value
$52.78K
Shares Held After
11,001
% of Holdings
4.2%
CYPHERPUNK TECHNOLOGIES INC. (CYPH)
Dietz Thomas John — Director
Shares
20,000
Price
$1.72
Total Value
$34.40K
Shares Held After
132,500
% of Holdings
13.1%
Immatics N.V. (IMTX)
PERCEPTIVE ADVISORS LLC — Director
Shares
863,060
Price
$8.69
Total Value
$7.50M
Shares Held After
11,246,516
% of Holdings
7.7%
Entrada Therapeutics, Inc. (TRDA)
MPM BIOVENTURES 2018, L.P. — 10% Owner
Shares
14,569
Price
$7.06
Total Value
$102.86K
Shares Held After
4,318,348
% of Holdings
0.3%
Entrada Therapeutics, Inc. (TRDA)
MPM BioVentures 2014, L.P. — 10% Owner
Shares
14,569
Price
$7.06
Total Value
$102.86K
Shares Held After
4,318,348
% of Holdings
0.3%
Adlai Nortye Group Ltd. (ANL)
Ye Xiaofeng — CFO
Shares
5,667
Price
$14.25
Total Value
$80.75K
Shares Held After
147,757
% of Holdings
3.7%
EXOZYMES INC. (EXOZ)
Heltzen Michael — Chief Executive Officer
Shares
100
Price
$7.50
Total Value
$750.00
Shares Held After
13,953
% of Holdings
0.7%
EXOZYMES INC. (EXOZ)
Heltzen Michael — Chief Executive Officer
Shares
250
Price
$7.52
Total Value
$1.88K
Shares Held After
14,203
% of Holdings
1.8%
Emmaus Life Sciences, Inc. (EMMA)
LEE WILLIS C — Director
Shares
46,000
Price
$0.04
Total Value
$1.84K
Shares Held After
445,400
% of Holdings
10.3%
Relay Therapeutics, Inc. (RLAY)
SVF Pauling (Cayman) Ltd — 10% Owner
Shares
6,000,000
Price
$19.40
Total Value
$116.40M
Shares Held After
21,904,963
% of Holdings
21.5%
Monopar Therapeutics (MNPR)
Anderson Raymond — Director
Shares
1,802
Price
$113.05
Total Value
$203.72K
Shares Held After
23,751
% of Holdings
7.1%
Monopar Therapeutics (MNPR)
Anderson Raymond — Director
Shares
646
Price
$110.07
Total Value
$71.11K
Shares Held After
25,523
% of Holdings
2.5%
Monopar Therapeutics (MNPR)
Anderson Raymond — Director
Shares
694
Price
$110.04
Total Value
$76.37K
Shares Held After
26,169
% of Holdings
2.6%
BeOne Medicines Ltd. (ONC)
Wu Xiaobin — President and COO
Shares
280
Price
$380.00
Total Value
$106.40K
Shares Held After
0
% of Holdings
100.0%
Q32 Bio Inc. (QTTB)
Kalowski Lee — CFO and President
Shares
3,972
Price
$16.56
Total Value
$65.78K
Shares Held After
138,471
% of Holdings
2.8%
Acrivon Therapeutics, Inc. (ACRV)
Blume-Jensen Peter — Director
Shares
14,036
Price
$2.21
Total Value
$30.97K
Shares Held After
2,230,052
% of Holdings
0.6%
Q32 Bio Inc. (QTTB)
Morrison Jodie Pope — Director
Shares
9,845
Price
$16.56
Total Value
$163.03K
Shares Held After
343,259
% of Holdings
2.8%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
5,870
Price
$126.06
Total Value
$739.97K
Shares Held After
9,755
% of Holdings
37.6%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
25,085
Price
$125.47
Total Value
$3.15M
Shares Held After
15,625
% of Holdings
61.6%
Q32 Bio Inc. (QTTB)
Violette Shelia M. — Chief Scientific Officer
Shares
2,798
Price
$16.56
Total Value
$46.33K
Shares Held After
127,771
% of Holdings
2.1%
Rapport Therapeutics, Inc. (RAPP)
Yeleswaram Krishnaswamy — Chief Development Officer
Shares
16,201
Price
$51.06
Total Value
$827.18K
Shares Held After
195,862
% of Holdings
7.6%
Rapport Therapeutics, Inc. (RAPP)
Yeleswaram Krishnaswamy — Chief Development Officer
Shares
20,799
Price
$50.31
Total Value
$1.05M
Shares Held After
212,063
% of Holdings
8.9%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
18,921
Price
$49.57
Total Value
$937.96K
Shares Held After
467,187
% of Holdings
3.9%
Entrada Therapeutics, Inc. (TRDA)
MPM BIOVENTURES 2018, L.P. — 10% Owner
Shares
26,522
Price
$7.54
Total Value
$199.98K
Shares Held After
4,332,917
% of Holdings
0.6%
Entrada Therapeutics, Inc. (TRDA)
MPM BioVentures 2014, L.P. — 10% Owner
Shares
26,522
Price
$7.54
Total Value
$199.98K
Shares Held After
4,332,917
% of Holdings
0.6%
Disc Medicine, Inc. (IRON)
Yu Jonathan Yen-Wen — Chief Operating Officer
Shares
8,796
Price
$83.12
Total Value
$731.09K
Shares Held After
54,324
% of Holdings
13.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$520.50
Total Value
$41.64K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
668
Price
$519.91
Total Value
$347.30K
Shares Held After
324,523
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,387
Price
$518.80
Total Value
$1.24M
Shares Held After
325,191
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,004
Price
$518.08
Total Value
$1.04M
Shares Held After
327,578
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,332
Price
$516.95
Total Value
$1.21M
Shares Held After
329,582
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,029
Price
$516.12
Total Value
$1.05M
Shares Held After
331,914
% of Holdings
0.6%
Tectonic Therapeutic, Inc. (TECX)
McNamara Peter — Chief Scientific Officer
Shares
43
Price
$36.52
Total Value
$1.57K
Shares Held After
55,285
% of Holdings
0.1%
CEL SCI CORP (CVM)
KERSTEN GEERT R — Director
Shares
100,000
Price
$1.38
Total Value
$138.00K
Shares Held After
316,142
% of Holdings
31.6%
PRECIGEN, INC. (PGEN)
Tennant Phil — Chief Commercial Officer
Shares
79,166
Price
$7.50
Total Value
$593.75K
Shares Held After
141,992
% of Holdings
35.8%
PRECIGEN, INC. (PGEN)
Shah Rutul R — Chief Operating Officer
Shares
15,342
Price
$7.50
Total Value
$115.06K
Shares Held After
468,865
% of Holdings
3.2%
Showing 151–200 of 1053 transactions (page 4 of 22)